The in vitro cytotoxicity and hemocompatibility of the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf biomedical shape memory alloys (SMAs) were investigated by cell culture (L-929 fibroblast cell), hemolytic test and platelet adhesion test, with CP Ti as a reference material. The cytotoxicity test indicates that all the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs show over 94% cell viability for different incubation times (2, 4 and 7 days) in comparison with a negative control and CP Ti. The cell morphology observation shows good polygon-like adherent growth and proliferation of L-929 in the extracts of all the test samples and CP Ti. These results suggest excellent cytocompatibility for the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs. The hemolytic test reveals that the hemolysis ratios of the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf alloys are far less than 5%, so they cannot give rise to acute hemolysis. The platelet morphology observation shows almost the same adhered platelet morphology and activation ratio for the test samples in comparison with CP Ti, except the Ti-22Nb-6Hf alloy, which shows a lower activation ratio of platelets, indicating excellent blood compatibility. Therefore, it is proposed that the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs will be candidates to replace Ti-Ni for biomedical applications.
Introduction
Recently, Ti-Ni shape memory alloys (SMAs) have gained attraction and also shown a remarkable increase in their use for biomedical applications such as orthodontic wire, vascular stent, guide wire and many kinds of other medical devices in the field of orthopedics or osteosynthesis, particularly because of their unique shape memory and super-elastic properties [1, 2] . However, there has been great interest in the biocompatibility of Ti-Ni SMAs, especially in the nickel release from Ti-Ni alloys. Because of high nickel content (about 50 at% Ni in Ti-Ni), there might be risk of Ni hypersensitivity and potential toxicity which restricts its use for clinical purposes, which has been reported by many researchers [3∼6] . So, surface modification techniques have been introduced to improve the biocompatibility of the currently used Ti-Ni SMA implant, for example, coatings, ion implant, chemical and electrochemical etching, etc. It is now generally believed that the proper surface treatment and formation of a passivity layer are helpful for clinical applications [7, 8] . On the other hand, in pursuit of complete biosafety, Ni-free SMAs have been developed as an alternative to Ti-Ni SMAs. Based on the phase transformation of α to β in titanium alloys, a new type of Ti-based SMA has been developed [9] , which exhibits better biocompatibility compared with traditional α-Ti or (α+β) dual phase Ti alloys with only the addition of biocompatible, non-toxic β stabilizing elements [10] [11] [12] . Until now, many kinds of Ti-based SMAs have been reported, e.g. Ti-Mo-Sn [13] , TiMo-Ag [14] , Ti-Nb-Sn [15] , Ti-Nb-O [16] , Ti-Nb-Zr [17] , Ti-Nb-Ta [18] , Ti-Nb-Ge [19] , Ti-Nb-Ga [19] , etc. It has been confirmed that the addition of a third element is helpful to improve the memory property of the Ti-based SMAs. Zirconium and hafnium with complete mutual solubility in both α Ti and β Ti, which are located in the same group as titanium in the periodic table of elements, are selected as the additional elements by the authors. A series of Ni-free TiNb, Ti-Nb-Zr and Ti-Nb-Hf SMAs has been prepared, which exhibit excellent corrosion resistance [20, 21] . In addition, the completely recoverable strain reaches 3% with the addition of the Zr or Hf elements. The recovery strain of Ti-Nb binary alloys is only 2%. The detailed results on the shape memory effect and its mechanism will be reported elsewhere.
It is necessary to evaluate various performances of Ni-free Ti-based SMAs. Nowadays, the evaluations of biocompatibility are increasingly performed using an in vitro cell culture technique, which can provide lower cost, faster and higher reproducibility results than an in vivo evaluation. It is also proved that the results of the cytotoxicity evaluation correlate well to the levels of inflammation observed by in vivo implant tests [22] . Cytocompatibility of the Ti-Mo-Al SMAs was evaluated using human normal diploid fibroblast HEL299. The experimental results indicated that the Ti-MoAl alloys had higher cytocompatibility than the Ti-Ni alloy [23] . However, the cytotoxicity of these Ni-free Ti-Nb, TiNb-Zr, and Ti-Nb-Hf SMAs has never been evaluated in vitro or in vivo. In addition, the hemocompatibility of materials used for contact with blood must be evaluated. The aims of the present study are mainly to investigate the cytotoxicity and hemocompatibility of Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs by cell culture, hemolytic test and platelet adhesion test. The effect of surface roughness on the behavior of platelet adhesion is also investigated.
Experimental details
The ingots with nominal compositions of Ti-xNb (x = 22, 26.5 and 35 at%) and Ti-22Nb-yZr/Hf (y = 2, 4 and 6 at%) were prepared from 99.99% purity Ti, Nb, Zr and Hf by means of non-consumable arc melting under Ar atmosphere. To improve the homogeneity, all of the ingots were re-melted five times and then cold-rolled by 90% reduction in thickness. After that, the cold-rolled plates were solid solution treated at 900
• C for half an hour and quenched into iced water. All of the samples with a size of 10 × 10 × 1 mm 3 were cut by electro-discharge machining. Surfaces of some of the samples were mechanical polished to a final level of 0.05 μm alumina, and others were ground with 2000 grade silicon carbide paper. Before the biocompatibility evaluations, all the samples were ultrasonically cleaned using acetone, alcohol and de-ionized water for 15 min.
The cytotoxicity of biomedical Ti-Nb, Ti-Nb-Zr and TiNb-Hf SMAs was evaluated by the indirect contact method using L-929 murine fibroblast cells. The samples were sterilized at 170
• C for 2 h. Then, the extracts were conducted using Dulbecco's modified Eagle medium (DMEM) with the surface area of extraction medium ratio 1.25 ml cm −2 in an atmosphere of 5% CO 2 at 37
• C for 72 h. The extracts, DMEM and 0.64% phenol DMEM were used as test sample groups, negative control group and positive control group, respectively. L-929 cells were cultured in DMEM supplemented with 10% fetal calf serum (FCS) at 37
• C in a humidified atmosphere of 5% CO 2 . 100 μl of cell suspension with 5 × 10 3 cells was seeded onto the bottom of the 96-well cell culture plate and then was cultured for 24 h to allow attachment. After that, the 96-well cell culture plate was emptied and cleaned twice using a phosphate buffer solution (PBS). 100 μl of extracts, DMEM and 0.64% phenol DMEM were added into each well. The cells were continuously incubated at the same temperature and humidity for 2, 4 and 7 days and were observed using an inverting microscope. After that, 0.005 mg/10 μl methylthiazol tetrazolium (MTT) was added to each well. The cells were incubated in the mixture of MTT and DMEM for 4 h; then each well was washed three times using PBS. 150 μl of dimethyl sulfoxide (DMSO) was added to each well to dissolve the cells. The optical absorbance (OD) of the supernatant was measured at a wavelength of 570 nm (630 nm reference) five times. The relative growth rate (RGR) of the L929 cells was calculated according to formula (1) . Statistical procedures were performed with SPSS 16.0. The significance of the obtained data was measured using one-way ANOVA, followed by Tukey's test for a multiple comparison procedure with a confidence level of 95% (p < 0.05) considered statistically significant and 99% (p < 0.01) considered very significant:
The hemocompatibility was evaluated by hemolysis and the platelet adhesion test. In the hemolysis test, 1 ml of 2% potassium oxalate solution was added into 20 ml of fresh rabbit blood for anticoagulation treatment. All the test samples were dipped into silanized glass tubes with 10 ml of 0.9% saline and incubated at 37
• C for 30 min. At the same time, the negative control (10 ml of 0.9% saline) and the positive control (10 ml of de-ionized water) were also incubated at 37
• C for 30 min. During this treatment, the rabbit blood was diluted with 25 ml of 0.9% saline. Then, 0.2 ml of diluted blood was added into each glass tube and the mixtures were incubated for 60 min at 37
• C. Afterward, the suspensions were centrifuged at a rate of 3000 rmp for 5 min. The absorbance of the supernatants was obtained using an ultraviolet spectrophotometer (UV-752). Each hemolysis result was an average of three measurements. The hemolysis was calculated based on the formula
In the platelet adhesion test, 45 ml of fresh rabbit blood was first mixed with 5 ml of acid-citrate-dextrose (ACD) for anticoagulation. Platelet-rich plasma (PRP) was obtained by centrifuging whole blood for 15 min at a rate of 2000 rpm. The PRP was dropped on the surface of the test samples to incubate at 37
• C for 1 h. After that, the PRP was discarded and the samples were gently rinsed with PBS three times to remove the non-adherent platelets on the sample surface. Then, the adherent platelets were fixed by dipping the samples into 2.5% glutaraldehyde solutions for 1 h at room temperature. After fixation, the samples were washed and subsequently dehydrated in a series of alcohol-distilled water mixture (30%, 50%, 70%, 90% and 100% alcohol) for 15 min sequentially. After dehydration, the samples were dealcoholized in a series of isoamyl acetate-alcohol solution (30%, 50%, 70%, 90% and 100% isoamyl acetate) for another 15 min. After the test sample was critical point dried and coated with gold, the platelet morphology adhered to its surface was observed by a scanning electron microscope (JSM 6480, Japan Electronics). The quality and activation of adherent platelets were examined by ten fields of view randomly selected to obtain good statistics.
Results and discussion
The cell viability was evaluated by measuring the value of optical absorbance, which indicated the activity of succinate dehydrogenase within the mitochondria being treated by the MTT method. The experimental results are shown in table 1. Figure 1(a) shows the viability of murine fibroblast cells L-929 after being cultured in the extracts of the test samples and CP Ti for different periods (2, 4 and 7 days), which were expressed as a percentage of the viability of cells cultured in the negative control. From this figure, it can be seen that the extracts of all of the test samples show over 94% cell survival rate for different incubation times (2, 4 and 7 days). However, the cell survival rate of the positive control is less than 25% after being cultured for only 2 days. After 2 day culture, compared with the negative control, the Ti-22Nb-4Hf group showed significantly higher cell viability values (p < 0.05). After 4 day culture, only the Ti-22Nb group showed significantly higher values than the negative control (p < 0.01). After 7 day culture, the Ti group (p < 0.05) and the Ti-22Nb-4Zr group (p < 0.01) showed significantly higher values, whereas the Ti-26.5Nb group showed significantly lower values in comparison with the negative control. Cells cultured in the extracts of all the test samples showed significantly higher with time, which indicates good cell growth. The value of OD is about 0.14-0.18 for the L-929 cell cultured for 2 days under the current culture conditions. After the cell is cultured for 4 days, the value increases to about 0.5-0.6. The highest values of OD are observed when L-929 cells are cultured for 7 days. According to RGR and OD, it can be seen that the extracts of all the test samples do not induce cytotoxic response for L-929 fibroblast cells, indicating that the additions of Nb, Zr and Hf elements into Ti would not induce cytotoxicity. Therefore, the biocompatibility of Ti-xNb and Ti-22Nb-yZr/Hf is judged to be excellent. Figures 2 and 3 show the typically optical morphologies of L-929 cells cultured for 2 days and 4 days in the extracts of test samples and controls, respectively. For the positive control, it can be seen that the cell proliferation of the L-929 cell is obviously inhibited after being cultured for only 2 days. The vast majority of cells fall off, which becomes more obvious after being cultured for 7 days. The exfoliated cells present with round shape, thick epicyte, uneven cytoplasm, vacuolar degeneration and granular material appeared in the cytoplasm. The nucleolus density increases and the nucleocytoplasmic ratio decreases. However, most of the cells cultured in the extract of the reference material (CP Ti) grow well and the cell proliferation has not been inhibited. The cells cultured in the extracts of the test samples show a similar attachment and proliferation to that in the extract of CP Ti. In each group, the vast majority of L-929 cells present with polygon-like adherent growth, but very few cells detach. Comparing these two figures, an increase in the numbers of the cells is also observed, which demonstrates the cell viability qualitatively. Therefore, all the results suggest excellent cytocompatibility for the Ti-Nb, Ti-Nb-Zr and TiNb-Hf biomedical SMAs. Zr and Hf elements can be used as non-toxic alloying elements to improve the memory properties. Figure 4 shows the hemolysis ratios of Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs, with CP Ti as reference material. The hemolytic activity is assessed by determining the hemoglobin release during the process of destruction of hematid. All samples are ground with waterproof silicon carbide paper upto 2000 grade. In order to investigate the effect of surface finish on the hemolysis, one of the Ti-22Nb-4Hf alloys is polished. The hemolysis ratio of the reference material (CP Ti) is 0.2%. Except for the Ti-35Nb alloy, the hemolysis ratios determined from other test samples do not exceed the hemolysis ratio of the reference material and are far less than 5%. For the Ti35Nb alloy with high Nb content, the hemolysis ratio is 0.3%. Although its hemolysis ratio is higher than that of CP Ti, it is still less than 5%. There is no obvious difference in the hemolysis ratio observed between the polished and ground Ti-22Nb-4Hf alloys. The hemolysis data suggest that all the test samples can meet the hemocompatibility requirements of biomedical implants, so they cannot give rise to acute hemolysis.
The macroscopic and microscopic SEM morphologies of platelets adhered to the surface of cloth polished test materials and CP Ti are displayed in figures 5 and 6, respectively. According to Goodman et al [24] The number and the degree of activation of adherent platelets are usually measured to assess hemocompatibility, but the degree of activation of adhered platelets would make more sense than adhesion behavior. Figure 8 shows the adhesion number and the activation degree of platelets adhered to the surfaces of Ti and the test materials. The platelet activation ratio on the surface of Ti-Nb-based alloys is almost the same as that on the surface of Ti, whereas the Ti-22Nb-6Hf alloy shows a lower platelet activation ratio than that on the surface of Ti. In addition, the Ti-22Nb-6Hf alloy with a rougher surface shows a higher platelet activation ratio. We used the clinically used Ti as a reference material, so the present hemolysis test and platelet adhesion results mean that the Nb, Zr and Hf elements have good blood compatibility and the Ti-Nb-based alloys are bio-safe. However, the rough surface increases the degree of platelet activation. In general, biomaterials in clinical use may have a wide range of surface roughness. However, some results obtained under laboratory conditions are often carried out using well-defined biomaterials with smooth surfaces. The requirement for the surface roughness of biomaterials strongly depends on their specific applications. If these alloys are used as stent materials, they must be used carefully so as to avoid the rough surface, which causes severe platelet activation and influences thrombosis and neointimal hyperplasia. However, if these materials are used for the replacement of hard tissue, a suitable roughness can favor cell adhesion. It has been reported that ZrO 2 Y 2 O 3 with Ra values less than 0.1 μm could be more favorable to fibroblast adhesion [25] .
Conclusions
The cytotoxicity of the biomedical Ti-Nb, Ti-Nb-Zr and TiNb-Hf SMAs is evaluated using the L-929 cell derived from mice. The results of the evaluations by the MTT method show that the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs are highly biocompatible. Zr and Hf are nontoxic elements that can be used as alloying elements to improve the memory effect. The hemolysis ratio of the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs is far less than 5%, indicating that all the test materials can meet the hemocompatibility requirements of biomedical implants. The adhered platelet morphology on the surfaces of Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs is almost the same as that on the surface of CP Ti. In addition, the Ti-Nb-Hf alloy exhibits a comparative or even lower activation ratio. Both the hemolysis test and platelet adhesion test show excellent hemocompatibility for the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs. However, the rough surface can induce a more severe activation of platelets than the smooth surface.
